Voyager Therapeutics (VYGR) Enterprise Value Growth (5y) (2019 - 2026)

Voyager Therapeutics (VYGR) Enterprise Value Growth (5y) (2019 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn -
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn -
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn
7 Belite Bio 61.40 Bn 61.40 Bn -
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn
9 Revolution Medicines 37.37 Bn 37.37 Bn -
10 Voyager Therapeutics 184.74 Mn 43.26 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2026 2.61%
Dec 31, 2025 -1.64%
Sep 30, 2025 -0.88%
Jun 30, 2025 1.26%
Mar 31, 2025 1.22%
Dec 31, 2024 1.08%
Sep 30, 2024 -2.36%
Jun 30, 2024 -2.53%
Mar 31, 2024 -2.19%
Dec 31, 2023 -8.18%
Sep 30, 2023 -7.09%
Jun 30, 2023 -6.82%
Mar 31, 2023 -4.61%
Dec 31, 2022 6.80%
Sep 30, 2022 -0.95%
Jun 30, 2022 -0.94%
Mar 31, 2022 -1.14%
Dec 31, 2021 5.34%
Sep 30, 2021 8.66%
Jun 30, 2021 6.86%